These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 37080937)

  • 1. Activation of Embryonic Gene Transcription in Neural Precursor Cells Derived from the Induced Pluripotent Stem Cells of the Patients with Parkinson's Disease.
    Fedoseyeva VB; Novosadova EV; Nenasheva VV; Novosadova LV; Grivennikov IA; Tarantul VZ
    Biochemistry (Mosc); 2023 Apr; 88(4):515-525. PubMed ID: 37080937
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Parkinson's Disease-Associated Changes in the Expression of Neurotrophic Factors and their Receptors upon Neuronal Differentiation of Human Induced Pluripotent Stem Cells.
    Novosadova EV; Nenasheva VV; Makarova IV; Dolotov OV; Inozemtseva LS; Arsenyeva EL; Chernyshenko SV; Sultanov RI; Illarioshkin SN; Grivennikov IA; Tarantul VZ
    J Mol Neurosci; 2020 Apr; 70(4):514-521. PubMed ID: 31820346
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proneural transcription factor Atoh1 drives highly efficient differentiation of human pluripotent stem cells into dopaminergic neurons.
    Sagal J; Zhan X; Xu J; Tilghman J; Karuppagounder SS; Chen L; Dawson VL; Dawson TM; Laterra J; Ying M
    Stem Cells Transl Med; 2014 Aug; 3(8):888-98. PubMed ID: 24904172
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Parkinson's disease in a dish - Using stem cells as a molecular tool.
    Badger JL; Cordero-Llana O; Hartfield EM; Wade-Martins R
    Neuropharmacology; 2014 Jan; 76 Pt A():88-96. PubMed ID: 24035919
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Engraftable Induced Pluripotent Stem Cell-Derived Neural Precursors for Brain Repair.
    Zygogianni O; Kouroupi G; Taoufik E; Matsas R
    Methods Mol Biol; 2020; 2155():23-39. PubMed ID: 32474865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generation of Naivetropic Induced Pluripotent Stem Cells from Parkinson's Disease Patients for High-Efficiency Genetic Manipulation and Disease Modeling.
    Hu Z; Pu J; Jiang H; Zhong P; Qiu J; Li F; Wang X; Zhang B; Yan Z; Feng J
    Stem Cells Dev; 2015 Nov; 24(21):2591-604. PubMed ID: 26218671
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distinctive genomic signature of neural and intestinal organoids from familial Parkinson's disease patient-derived induced pluripotent stem cells.
    Son MY; Sim H; Son YS; Jung KB; Lee MO; Oh JH; Chung SK; Jung CR; Kim J
    Neuropathol Appl Neurobiol; 2017 Dec; 43(7):584-603. PubMed ID: 28235153
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficient induction of dopaminergic neuron differentiation from induced pluripotent stem cells reveals impaired mitophagy in PARK2 neurons.
    Suzuki S; Akamatsu W; Kisa F; Sone T; Ishikawa KI; Kuzumaki N; Katayama H; Miyawaki A; Hattori N; Okano H
    Biochem Biophys Res Commun; 2017 Jan; 483(1):88-93. PubMed ID: 28057485
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stress-induced precocious aging in PD-patient iPSC-derived NSCs may underlie the pathophysiology of Parkinson's disease.
    Zhu L; Sun C; Ren J; Wang G; Ma R; Sun L; Yang D; Gao S; Ning K; Wang Z; Chen X; Chen S; Zhu H; Gao Z; Xu J
    Cell Death Dis; 2019 Feb; 10(2):105. PubMed ID: 30718471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differentiation of Neural Stem Cells Derived from Induced Pluripotent Stem Cells into Dopaminergic Neurons.
    Daadi MM
    Methods Mol Biol; 2019; 1919():89-96. PubMed ID: 30656623
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pluripotent stem cell derived dopaminergic subpopulations model the selective neuron degeneration in Parkinson's disease.
    Oosterveen T; Garção P; Moles-Garcia E; Soleilhavoup C; Travaglio M; Sheraz S; Peltrini R; Patrick K; Labas V; Combes-Soia L; Marklund U; Hohenstein P; Panman L
    Stem Cell Reports; 2021 Nov; 16(11):2718-2735. PubMed ID: 34678205
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induced Pluripotent Stem Cell-Derived Dopaminergic Neurons from Familial Parkinson's Disease Patients Display α-Synuclein Pathology and Abnormal Mitochondrial Morphology.
    Diao X; Wang F; Becerra-Calixto A; Soto C; Mukherjee A
    Cells; 2021 Sep; 10(9):. PubMed ID: 34572052
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impairment of proteasome and anti-oxidative pathways in the induced pluripotent stem cell model for sporadic Parkinson's disease.
    Chang KH; Lee-Chen GJ; Wu YR; Chen YJ; Lin JL; Li M; Chen IC; Lo YS; Wu HC; Chen CM
    Parkinsonism Relat Disord; 2016 Mar; 24():81-8. PubMed ID: 26797011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular Features Underlying Neurodegeneration Identified through In Vitro Modeling of Genetically Diverse Parkinson's Disease Patients.
    Lin L; Göke J; Cukuroglu E; Dranias MR; VanDongen AM; Stanton LW
    Cell Rep; 2016 Jun; 15(11):2411-26. PubMed ID: 27264186
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Higher vulnerability and stress sensitivity of neuronal precursor cells carrying an alpha-synuclein gene triplication.
    Flierl A; Oliveira LM; Falomir-Lockhart LJ; Mak SK; Hesley J; Soldner F; Arndt-Jovin DJ; Jaenisch R; Langston JW; Jovin TM; Schüle B
    PLoS One; 2014; 9(11):e112413. PubMed ID: 25390032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcriptome Analysis of Induced Pluripotent Stem Cells and Neuronal Progenitor Cells, Derived from Discordant Monozygotic Twins with Parkinson's Disease.
    Vlasov IN; Alieva AK; Novosadova EV; Arsenyeva EL; Rosinskaya AV; Partevian SA; Grivennikov IA; Shadrina MI
    Cells; 2021 Dec; 10(12):. PubMed ID: 34943986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcription of
    Fedoseyeva VB; Novosadova EV; Nenasheva VV; Novosadova LV; Grivennikov IA; Tarantul VZ
    J Dev Biol; 2023 May; 11(2):. PubMed ID: 37367477
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Transcriptional Changes of trim Genes Associated with Parkinson's Disease on a Model of Human Induced Pluripotent Stem Cells.
    Nenasheva VV; Novosadova EV; Makarova IV; Lebedeva OS; Grefenshtein MA; Arsenyeva EL; Antonov SA; Grivennikov IA; Tarantul VZ
    Mol Neurobiol; 2017 Nov; 54(9):7204-7211. PubMed ID: 27796756
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induced pluripotent stem cell (iPSC)-derived dopaminergic models of Parkinson's disease.
    Beevers JE; Caffrey TM; Wade-Martins R
    Biochem Soc Trans; 2013 Dec; 41(6):1503-8. PubMed ID: 24256244
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic function of a novel rat induced pluripotent stem cell line in a 6‑OHDA‑induced rat model of Parkinson's disease.
    Xu J; Li Y; Zhu H; Wu W; Liu Y; Guo Y; Guan W; Liu C; Ma C
    Int J Mol Med; 2022 Dec; 50(6):. PubMed ID: 36300203
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.